JULIE CORTES: Open Payments
NPI 1710450226 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,524 in 147 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $1,334 · 2025 $4,524
Food & beverage: $3,270Travel & lodging: $1,155Education: $100
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 21 | $2,020 |
| Xeris Pharmaceuticals, Inc. | 20 | $379 |
| Novo Nordisk Inc | 15 | $250 |
| RECORDATI_RARE_DISEASES_INC. | 19 | $224 |
| Lilly USA, LLC | 11 | $217 |
| Amgen Inc. | 10 | $179 |
| Novartis Pharmaceuticals Corporation | 5 | $137 |
| Dexcom, Inc. | 6 | $131 |
| BETA BIONICS, INC. | 4 | $124 |
| Astellas Pharma US Inc | 1 | $100 |
Products named: MINIMED 780G, RECORLEV, ISTURISA, LEQVIO, Dexcom G6 Transmitter, TEPEZZA, Ozempic, iLet Bionic Pancreas.
Industry payments across CA — which companies pay providers there.
